From ideas...to medical applications
In the absence of any straightforward laboratory tests, the most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has...
From ideas...to medical applications
Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant...
From ideas...to medical applications
Listening to and exchanging ideas with members of the biomedical science community has enabled Stago to develop its expertise in the search for...
From ideas...to medical applications
Achieving a balanced policy with regard to investment in research & development (R&D), technological monitoring and rational acquisitions is a key...
June 29th - July 4th, 2013
July 28 - August 1, 2013
December 7 - 10, 2013
This 
free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.
STA®-Liquid Anti-Xa: the solution of choice for UFH, LMWH and Fondaparinux monitoring
Stago offers a comprehensive range for anticoagulant monitoring. The new STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH and...
Von Willebrand had first described in 1926 a haemorrhagic familial syndrome, inherited in a dominant manner, in a small ethnic group of Aaland islands, located in the Baltic sea, between Sweden and Finland.
